霍奇金淋巴瘤治疗患者再评估FDG PET/CT时偶然发现COVID-19感染
报告一例27岁女性ⅢE B期霍奇金淋巴瘤患者,在第4周期化疗后再评估FDG PET/CT时发现左肺胸膜下混合磨玻璃及实变影且FDG摄取增高,结合形态代谢特征与疫情背景怀疑病毒性肺炎,患者PET/CT后28小时出现发热,鼻咽拭子COVID-19阳性,转归良好。
要点
- 无症状COVID-19可在FDG PET/CT表现为胸膜下混合磨玻璃及实变影伴FDG摄取增高。
- 结合形态代谢特征与疫情背景应怀疑病毒性肺炎。
- 患者PET/CT后28小时出现发热,鼻咽拭子COVID-19阳性,转归良好。
核心结论
- 无症状COVID-19感染可在再评估FDG PET/CT上表现为胸膜下混合磨玻璃及实变影伴FDG摄取增高,结合疫情背景应怀疑病毒性肺炎。
研究设计与样本
- 本文报告一例27岁女性ⅢE B期霍奇金淋巴瘤患者在第4周期化疗后再评估FDG PET/CT的病例。
主要发现
- FDG PET/CT显示左肺为主的胸膜下混合磨玻璃及实变影,FDG摄取增高。
- 结合形态代谢特征与疫情背景怀疑病毒性肺炎。
- 患者初始无症状,PET/CT后28小时因发热入院。
- 鼻咽拭子COVID-19阳性,转归良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the results of F-FDG PET/CT in an asymptomatic case of COVID-19 infection. A 27-year-old woman underwent FDG PET/CT for revaluation of a stage IIIE B Hodgkin lymphoma after the fourth cycle of chemotherapy. It showed intense avid FDG subpleural mixed ground-glass and consolidative lesions, especially in the left lung. Because of this morpho-metabolic aspect and the epidemic context, a viral pneumopathy was suspected. The patient who was initially asymptomatic was admitted for fever 28 hours after the PET/CT. The nasopharyngeal swab was positive for COVID-19, and the outcome was favorable.
引用
- Simand C, Bund C, Guffroy B, et al. Incidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma. Clin Nucl Med. 2020. PMID: 32520506. doi:10.1097/RLU.0000000000003144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。